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Computed Tomography: A Comparative Study 
1006-176.4488 
Diagnostic Value of Two and Three-Dimensional 
Image Reconstruction Techniques for the 
Detection of Coronary Artery Stenoses by 
Contrast-Enhanced Electron-Beam CT 1033-28 
.416A 
Electron Beam CT-Determined Coronary Artery 
Calcium Is Correlated With Parameters of the 
Insulin Resistance Syndrome 1145-37 l 4638 
Frequency and Magnitude of Coronary Calcification 
in Patients With Early Plaque Formation After 
Heart Transplantation: Comparison Between 
Intracoronary Ultrasound and Electron Beam 
Computed Tomography 830-2*433A 
Impact of Age and Ethnicity on Coronary 
Calcification in the Women’s Health Initiative 
Observational Study 1145.34*462A 
National Guidelines May Not Accurately Reflect 
Atherosclerosis Risk in Women as Defined by 
Electron Beam Tomography 1145-35 l 462A 
Noninvasive Angiography With Multi-Detector 
Helical Computed Tomography for Evaluation 
of Coronary Artery Disease 1145-38 l 463A 
Noninvasive Coronary Angiography Using 
Contrast-Enhanced Magnetic Resonance 
Imaging and Electron Beam Computed 
Tomography: Comparison of the 
Contrast-to-Noise Ratio 1033-26.4158 
Noninvasive Quantification of Myocardial Perfusion 
Reserve With Electron Beam Computed 
Tomography in Comparison to Intracoronsry 
Blood Flow Reserve by Doppler Ultrasound 
904.I.4848 
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Prediction of Abnomal Coronary Flow Reserve 
With Electron Beam Computed Tomography for 
Coronary Calcification 904-4 *484A 
Prognostic Value of Coronary Calcification in a 
Chest Pain Population 1145-33 l 462A 
Progression of Coronary and Aortic Calcification in 
Middle-Aged Women as Measured by Electron 
Beam Tomography X30-4.433A 
Quantitative Evaluation of Intramyocardial 
Microvascular Function in 
Hypercholesterolemic Pigs Using Electron 
Beam Computed Tomography 1145-39 * 4638 
Eiectropharmacology 
Acute Effects of Dronedarone on Potassium Currents 
in isolated Rabbit Ventricular Myocytes: 
Comparison With Amiodarone 1030-99 l 98A 
Amiodarone Inhibits Cardiac ATP-Sensitive K+ 
Channels 1030-93 l 97A 
Electrophysiological Effects of Toborinone on 
Rabbit Heart Pacemaker and Purinie Cells 
1210.95 *157A 
H 345/52-A Novel Repolarization-Delaying 
Antiarrhythmic Agent With Greatly Reduced 
Proarrhythmic Potential 1030-94*97A 
The Antipsychotic Agents Thioridarine. 
Chlorpromazine, and Clozapine Block the 
Human-Ether-a-go-go Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 1030.97 l 98A 
Electrophysiology 
8-Br-cGMP Reverses Isoproterenol Induced 
Changes of Cardiac Single L-Type Calcium 
Channel Gating 121 O-97 l 158A 
A Constant Interval From the Stimulus Artifact to 
the Local Atrial Electrogram During Coronary 
Sinus Pacing: An Electrophysiologic Tool for 
Albation of Atrial Flutter 1074-67 l 109A 
A Randomized, Controlled Trial of Groin Shielding 
During Catheter Ablation and Cardiac 
Catheterization 1129-79 *54A 
A Single Anatomic Linear Lesion Prevents Induction 
of Uniform Ventricular Tachycardia in a Porcine 
Model of Healed Infarction 1187-98 = 150A 
Action Potential Remodeling in the Human Right 
Atrium With Chronic Lone Atria1 Fibrillation 
1164-68.139A 
Angiotensin II Antagonist Reduces 
Tachycardia-Induced Electrical Remodeling of 
the Atiiia 1030.100*98A 
Antiarrhythmic Drug Therapy in the Multicenter 
Unsustained Tachycardia Trial (MUSTT): 
Penetrating the Matrix 910.4.160A 
Antiarrhythmic Effects of a Novel Cardioprotective 
Drug, 3TV519, on Atria1 Fibrillation and Flutter 
in the Canine Sterile Pericarditis Model 
1030.98 *98A 
Assessing Myocardial Viability Using NOGA Left 
Ventricular Mapping System in a Chronic 
Ischemic Porcine Model: A Con-elation With 
Histology and Thallium Scintigraphy 1079-38 * 
430A 
Changes in P-Wave Dispersion and P-Wave Duration 
Following Open Heart Surgery Correlate With 
the Peak Incidence of Atria1 Fibrillation 
1164.73 * 140A 
Characterization of Pulmonary Vein Anatomy and 
Physiology in Patients With and Without Atria1 
Fibrillation 866-l *131A 
Clinical Significance of Focal Atrial Arrhythmias 
Following Cardioversion of Persistent Atria1 
Fibrillation 1209.72 *156A 
Development of Impressive Neovascularization in 
Chronic Radiofrequency Energy Lesions 
1186.73 l 149A 
Differential Effects of Anesthesia on 
Atrioventricuiar Nodal Fast and Slow Pathways 
1140.71. X34A 
Effects of Adrenergic Stimulation on Atria1 
Electrical Activity During Atria1 Fibrillation 
1164-70 * 140A 
Electroanatomical Left Ventricular Mapping 
(NOGA) for Prediction of Functional Recovery 
1095.142*185A 
Electrophysiological Mapping and Histological 
Examinations of the Swine Atrium With 
Sustained Atria1 Fibrillation: A Suitable Animal 
Model for Studying Human Atria1 Fibrillation 
866-6 l 132A 
Evolution of Ventricular Fibrillation in a Canine 
Model 11X7-95 l 150A 
Exercise Noise Seen by Pacemaker From Leads 
1075.96*112A 
Feasibility of Ablation of Focal Atria1 Fibrillation 
Guided by Noncontact Left Atrial Mapping 
802-5 l 123A 
Feasibility of Combined Noncontact and 
Electmanatomical Mapping for Guiding 
Ablation of Complex Arrhythmias 1 I 1X-72 l 
126A 
Inducibility of Ventricular Tachycardia After Dor 
Procedures 1128.133.383A 
Is It Necessary to Prove Bidirectional Block After 
Unidirectional Block at a Long Pacing Cycle 
Length? 1210-93 l 157A 
Localization of the Orifice of the Pulmonary Veins 
by Unipolar and Bipolar Impedance 
Measurements 1074-71 l 1lOA 
Manifestation of Antidromic Reciprocating 
Tachycardia in Subjects With Paraseptal 
Accessory Pathways 1209-68 l 155A 
New Electrophysiological Finding Favoring the 
Existence of a Distal Common Pathway in 
Atioventricular Nodal Reentrant Tachycardias 
1140-67 l 133A 
Organized and Reproducible Atria1 Activation Is 
Present Globally and Regionally During Phases 
of Human Atrial Fibrillation 1164-69 - 139A 
Origin of Junctional Tachycardia During 
Radiofrequency Ablation of Atrioventtical 
Nodal Reentrant Tachycardia in Humans 
1140-69 l 133A 
Overlapping Cycle Index: A Marker for the 
Prediction of the Outcome of Near Defibrillation 
Threshold Shocks 414.2*552A 
Potential for Intraahial Reentrant Tachycardia Prior 
to the Fontan Operation 1170-160*515A 
Pure Iridium Metal Microelectrode for 
Trammembrane Potential Recording in Isolated 
Swine Right Ventricle 1186-68 l 147A 
Reduced B-Adrenergic Responsiveness of Calcium 
Inward Cutrents in Human Atria1 Myocytes of 
Patients With Heart Failure 883-60 147A 
Right Atrial Postero-Septal Double Potentials as an 
Indicator of Left Atrial Origin of Ectopic 
Tachycardia 1118-68 l 125A 
Short-Term Electrophysiological Changes of the 
Atria After Internal Cardioversion: Cause of 
Immediate Reinitiation of Atrial Fibrillation? 
1164-67 l 139A 
Single Puncture, Repeated, and Multicenter 
Transseptal Electrophysiological Access to the 
LeftAtrium 111%73.1268 
Source of Trigger Ca2+ fpr CICR Is Swtched From 
Ca2+ Channels to Na+-Ca2+ Exchangers 
During Heart Failure Transition in Hypertrophic 
Rat Ventricular Myocytes 1186-69 l 148A 
Spectral Analysis of Atrioventricular Conduction 
Time Variability: A New Method for 
Quantitative Evaluation of the Effect of 
Autonomic Nervous Activity on the 
Atrioventricular Node 848-2 l 123A 
Spontaneous Atrial Fibrillation Is Initiated by 
Premature Beats From Different Atrial Regions 
and Involves Atria1 Regions Adjacent to the 
Trigger(s) at Initiation 1209-71 l 156A 
T-Wave Altemans During Ventricular Pacing 880-6 
l 145A 
The Antipsychotic Agents Thioridazine, 
Chlorpromazine, and Clozapine Block the 
Human-Ether-a-go-go Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 1030-97 l 9SA 
The Presence of a Left Atria1 “Isthmus”: 
Implications for Radiofrequency Ablation of 
Lateral Accessory Pathways 1210.94*157A 
The Value of Bundle Branch or Fascicle Block in 
Locating the Site of Septal Accessory Pathway 
1209.69 l 155A 
SUBJECT INDEX 645A 
Time Course of Atrial Electrical Remodeling After 
Conversion of Chronic Atrial Fibrillation: Is It 
Related With Recurrence? 866-5 l 132A 
Transcription Factors in the Pwkinje Fibers 
1186-67 l 147A 
Transmural Dispersion of Repolarizatlon Recorded 
During Acute Myocardial Ischemia in In Situ 
Canine Hearts 1187.940 149A 
Use of an Implantable Loop Recorder in Patients 
With Recurrent Syncope of Unknown Origin Is 
a Cost-Effective Diagnostic Strategy 1120-61* 
129A 
Emergency care 
A Critical Pathway for Chest Pain Patients Allow 
Acute Triaging Within 90 Minutes of 
Presentation to the Emergency Room 1127-136 
l 379A 
An Emergency Department Chest Pain Center 
Impacts the Disposition of All Patients With 
Acute Chest Pain: A Two-Year Registry 
1216.13.559A 
Comparison of a Biphasic Tnmcated Exponential 
Waveform to Two Standard Monophasic 
Waveforms for External Defibrillation 889-20 
400A 
Emergency Access to the Thoracic Central Venous 
Circulation Using Femoral Venipuncture During 
Cardiopulmonary Resuscitation 1174-128. 
399A 
Emergency Hospital Admission of Adults With 
Congenital Heti Disease: A Multicenter Study 
1103-164.5038 
Impact of an Emergency Department Cardiac 
Clinical Decision Unit on a Population of 
Patients With Episodic Chest Discomfort 
1127.138*380A 
Is Quantitative Bedside Determination of Troponin T 
Equal to Laboratory Testing? Results of a 
German Multicenter Study of Emergency 
Rooms 1082-107*362A 
Judicious Use of Radionuclide Myocardial Perfusion 
Imaging in an Emergency Department Chest 
Pain Center Optimizes the Triage of Patients 
With Chest Pain 884.4*474A 
Low-Risk Patients Undergoing Evaluation of Acute 
Chest Pain Do Not Benefit From Heart Rhythm 
Monitoring 1174-130 l 3998 
Secure and Accessible Electronic Medical Records: 
Setting Up Your Own Reliable, Low-Cost 
Web-Based System 1503-l l 554A 
Usefulness of a Rapid, Bedside Test for Brain 
Natriuretic Peptide in the Evaluation of Patients 
Presenting to the Emergency Room With 
Possible Congestive Heart Failure 1049-152. 
171A 
Endocarditis 
Clinical Course of Infective Endocarditis in the 
Years 1996-1998: Preliminary Results of the 
ALKK Endocarditis Registry 1205-65 l 537A 
Determinants of Acute and Long-Term Survival in 
245 Patients With Infective Endocarditis 
1205-63 l 536A 
Factors Associated With Increased Morbidity and 
Mortality in the Initial Assessment of Patients 
Presenting With Acute Infective Endocarditis 
1205-66.537A 
Is Echocardiography Cost-Effective in the Diagnosis 
and Treatment of Endocarditis? 1122.31*452A 
Long-Term Outcome of Surgical Versus Medical 
Treatment in Endocarditis Complicated by 
Perivalvular Abscess 83 l -4.529A 
Predictive Factors of Systematic Embolism in 
Left-Sided Infective Endocarditis 1205-640 
536A 
Prospective Evaluation of Clinical Criteria for the 
Diagnosis of Pacemaker Lead Infection 
1075-97 l 112A 
Endothelin 
Acute Hemodynamic and Neurohumoral Effects of 
Selective ETA Receptor Blockade in Patients 
With Congestive Heart Failure 909-5 l 241A 
Chronic Endothelin A Receptor Antagonism 
Improves Vasorelaxations to Natriuretic 
Peptides in Atherosclerosis 1178-53.3168 
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Endothelin-1 Increases Diastolic Distensibility of 
Human and Nonhuman Myocardium in 
Conditions of Cardiac Overload 865-3 l 204A 
Endothelin-1 Suppresses Nitric Oxide Induced 
Caspase-3 Activation and Antagonizes 
Apoptosis in Cardiomyocytes 104%1470 170A 
Endothelin-1, Nitric Oxide Metabolites, Left 
Ventricular Mass, and Hemodynamic Responses 
to Vasoconstrictive Stress in Normotensive 
Youth 1181.22*321A 
Functional Significance of G-33A Promoter 
Mutation of Thrombodulin Gene and Its 
Influence on Plasma Soluble Thrombomodulin 
Level in Patients With Coronary Artery Disease 
1066.44*259A 
Improved Hemodynatnics With the ETA Selective 
Receptor Antagonist BMS-193884 in Patients 
With Heart Failure 909.6.2418 
Increased Endothelin-1 Concentrations in Response 
to Pulmonary Hypertension in the Newborn 
Lamb 1113-50*285A 
Induction of Endothelin-1 Expression by Oxidative 
Stress in Vascular Smooth Muscle Cells 
1133-46 l 2948 
Is There a Release of Endothelin-I During Exercise 
Testing in Patients With Syndrome X? 
1061.129.3538 
Mechanical Unloading Versus Neurohumoral 
Stimulation on Myocardial Structure and 
Endocrine Function In Viva 803-3 l 2OOA 
Neurohumoral Response During Exercise in Healthy 
Controls and Patients With Chronic Heart 
Failure 1071.144.1758 
Noninvasive Assessment of Exercise-Induced 
Alterations of the Conduit Artery Tone in 
Healthy Controls and Patients With Chronic 
Heart Failure: Relationship to Endothelin-1 and 
Norepinephrine 1071.150*177A 
Obesity, a Cardiovascular Risk Factor, Is Associated 
With Tissue-Specific Activation of Renal 
Angiotensin Converting Enzyme Activity In 
Vivo: Evidence for a Regulatory Role of 
Engothelin 1133-45 l 294A 
Plasma Atrial Nattiuretic Peptide, Cyclic Guanosine 
Monophosphate, and Endothelin Response to 
Omapatrilat in Heart Failure 1137-1440206A 
Role of ET-l in Foam Cell Formation by Human 
Macrophages In Vitro 1178-58*317A 
Superiority of Mixed ET .4/B Over Specific ETA 
Antagonist in Treatment of Pulmonary 
Hypertension and Right Ventricular 
Hypertrophy in the Monocrotaline Rat Model 
894-4 l 3238 
Systemic and Pulmonary Hemodynamic Effects of 
Endotracheal Aitway Receptor Antagonism 
1025-19*249A 
The Contribution of Endothelin to Pulmonary 
Vascular Tone Under Normoxic and Hypoxic 
Conditions 868-3 l 290A 
Use of the Apical Sound Window Involves 
Tangential Cuts of the Left Ventricle: Proof of 
the Hypothesis Using Real-Time 
Three-Dimensional Imaging and Volumetry 
116%6*468A 
Endothelium 
Absehce of L-Arginine Effect on the Coronary 
Hypersensitivity to Serotonin in Cardiac 
Transplant Recipients 120X-120 l 238A 
Activated T-Cells Stimulate Endothelial Cells to 
Release Pro-Inflammatoty Cytokines in a 
Contact-Dependent Manner: A Clue About the 
Pathogenesis of Atherosclerosis? 1178.54 l 
316A 
Activation of Mitogen Activated Protein Kinases by 
Monocyte Chemoattractant Protein-l in Human 
Endothelial Cells 1s Suppressed by a 
Cerivastatin 1044-SO*2508 
Activation of Protein Kinase A Inhibits Endothelial 
Cell Apoptosis Induced by Stimulation of the B 
Subtype of the Thromboxane Receptor 1157.55 
l 307A 
Adhesion Molecules in Patients With Coronary 
Artery Disease Are Markers of the Extent of 
Disease 1089-42*271A 
Alterations of Release Pattern of Endotbelial 
Dependent Hemostatic Factors and Cell 
Adhesion Molecules in Nonvalvular Atrial 
Fibrillation 1051-720103A 
Angiotensin Converting Enzyme Inhibition 
Improves Endolhelial Dysfunction and 
Myocardial Ischemia 1023.44*246A 
Angiotensin II Induces the NADPH Oxidase Subunit 
p22phox in Endothelial Cells: Effect on Platelet 
Derived Growth Factor Dependent Production 
of Reactive Oxygen Species 1133.43 l 294A 
Antisense Directed at Endothelium Oxidized LDL 
Receptor LOX-l Inhibits Apoptosis in Human 
Coronary Artery Endothelial Cells 1134.50. 
2958 
Arterial Flow-Mediated Dilatation Is Linearly 
Proportional to Vascular Wall Shear Stress: 
Endotbelial Function Assessed by Phase 
Contrast Magnetic Resonance Angiography 
414-3 l 553A 
Assessment of Leg Arterial Vasodilatory Capacity in 
Elderly Heart Failure Patients and Normals 
Using Phase Contrast Magnetic Resonance 
imaging 847-3 l 192A 
Barorecepter Dysfunction Induced by Nitric Oxide 
Synthase Inhibition in Humans 868-l l 290A 
Blunted Reactive Hyperaemia Is Associated With 
Reduced Tissue Plasminogen Activator Release 
in Atheroscerotic Men 1201-44*327A 
Bone Marrow-Dedved Endothelial Progenitor Cells 
Do Not Significantly Contribute to Angiogenesis 
in a Tumor Model 1092.24 l 2788 
Bradykinin-Induced Tissue Plasminogen Activator 
Release Is Enhanced by Angiotensin Converting 
Enzyme Inhibition but Not Angiotensin II 
Receptor Antagonism in Healthy Humans 
1023.45*246A 
Comparative Effects of Captopril and Losartan on 
Endothelial Function and Vascular Endothelial 
Growth Factor 860-3 l 288A 
Comparative Effects of Paroxetine and Nefazodone 
on Human Platelet Aggregation and Vascular 
Reactivity 832-402668 
Comparison of the Evaluation of Endothelial 
Function by Flow Mediated Dilation Using 
Brachial Artery or Popliteal Artery 1201-460 
327A 
Coronaty Artery Endotlxlial Protection Following 
Local Delivery of 17-B& Estradiol During 
Balloon Angioplasty: A Potential New 
Pharmacological Approach to Improve 
Long-Term Outcome of Angioplasty 1131.118 
-58A 
Coronaty Flow and Diameter Increase and 
Immediate Epicardial Endothelial Dysfunction 
Improvement by Quinaprilat Intracoronarily in 
Heart Transplant Recipients 1208.121 l 238A 
Creating Lipid-Rich Lesions in Porcine Coronary 
Arteries: A Novel Model of Vulnerable Plaque 
1133-48.2958 
Cycle-Oxygenase Inhibitor Diclofenac Improves 
Chlamydia Pneumoniae-Induced End&h&al 
Dysfunction 1022-56*244A 
Differential Cytotoxicity of Radiocontrast Agents on 
Human Umbilical Vein Endothelial Cell 
Monolayers In Vitro 1018.XO*ZA 
Divergent Effect of Eating Fat and Carbohydrate on 
Endothelial Function 1156.43 l 304A 
Early Neutrophil Recruitment and Intimal 
Hyperplasia: Studies in a Murine Model of 
Femoral Artery Transluminal Injury 1092-220 
2188 
Effect of Angiotensin AT1 Receptor Inhibition on 
Circulating Markers of Endothelial Dysfunction 
860-4 l 288A 
Effect of Chronic Exercise and Long-Term 
Angiotensin-Converting Enzyme Inhibitors on 
Endothelial Function of Rat Thoracic Aorta 
1089.49 l 273A 
Effects of Losartan on Endothelium-Dependent 
Vasodilation in Patients With Chronic Heart 
Failures 1045.42 l 254A 
Effects of Single-Drug Antihypertensive Therapy on 
Endothelium-Dependent Vasodilation in 
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Hypertensive Postmenopausal Women 860-l l 
287A 
Elevated Levels of Soluble Fas in Postmenopausal 
Women 1156-48.3058 
Endothelial Dysfunction Following Oral Methionine 
Is Not Mediated by an Increase in Free Radicals 
1089.48 l 273A 
Endothelial Dysfunction in Patients With Systemic 
Lupus Erythematosus 1156.49 l 305A 
Endothelial Nitric Oxide Synthase Is a Site of 
Superoxide Synthesis in Endothelial Cells 
Treated With Glyceryl Trinitrate 1044-57 l 
252A 
Endothelium-Dependent and Independent Vascular 
Responses and Blood Flow in the Brachial 
Artery of Healthy Controls and Patients With 
Chronic Heart Failure: Relationship to Peak 
Oxygen Consumption and Left Ventricular 
EjectionFraction 1071.149*177A 
Epineprine Induces Free Radical Release and 
Upregulates Endogenous Superoxide Dismutase 
Gene and Protein Expression in Human 
Coronary Artery Endothelial Cells 1050-121 l 
173A 
Estradiol Inhibits Nuclear Factor-kB Binding 
Activity In Vitro and In Viva 1044-51 l 250A 
Evidence of Prolonged Inflammation in Patients 
With Unstable Angina and Non Q-Wave 
Myocardial Infarction 1090.53 l 274A 
Exercise Perfusion Scintigraphy Positivity Is 
Associated With Peripheral Vascular End&h&al 
Dysfunction in Patients With Normal Coronary 
Arteries 1191.29*482A 
Free Radicals Mediate Coronary Vascular 
Dysfunction Associated With Direct Current 
Shocks 1089-46.2728 
Galectin-3 Accumulation in Foam Cells of 
Atherosclerotic Lesions and Lipid Loaded 
Mouse Peritoneal Macrophages 1133.41.2938 
Glutathione-Mediated Biotransformation of Glyceryl 
Trinitrate to Nitric Oxide: A Potential Role for 
Peroxynittite in Nitrate Tolerance in Patients 
With Unstable Angina 1156.44*304A 
Greater Endothelial Protection by the Vasopeptidase 
Inhibitor Omapatrilat Compared to the 
ACE-Inhibitor Captopril in Salt Induced 
Hypertension 102518.2488 
Homocysteine in Patients Is Associated With 
Surrogate Markers of Endothelial Dysfunction 
1089-47 l 272A 
Hypercholesterolemia and Hypertension Have a 
Synergistic Deleterious Effect on Coronary 
EndotbelialFunction 1089-45.2728 
Immediate and Long Term Endothelial Activation in 
Diabetics Patients With Acute Coronary 
Syndromes 1084-132-3668 
Inactivation of Nitric Oxide by Superoxide Is a 
Mechanism Leading to Age-Related Endothelial 
Dysfunction 1092.190277A 
Increased Adhesion Molecules Levels in Patients 
With Chest Pain and Normal Coronary 
Arteriograms 87 l-5 l 384A 
Inhibition of Angiogenesis by Peptides Derived 
From Kininogen Domain 5 and by a 
Monoclonal Antibody to Kininogen Domain 5 
1134-5 1 l 2958 
Is Endotoxin a Trigger in Congestive Heart Failure 
Patients With Acute Cardiogenic Pulmonary 
Edna? 1183.1500224A 
Local and Systemic Hemostatic and Fibrinolytic 
Effects of Intra-Arterial Desmopressin In Vivo 
in Humans: Role of Monocyte Activation 
1201.41 l 326A 
Long-Term Consequences of Coronary Aneurysms 
After Kawasaki Disease: Vascular Wall 
Morphology and Endothehum Function 
1146.161*513A 
Long-Term Exercise Training Leads to Sustained 
Improvement of Coronaty Endotbelial Function 
and Flow Reserve in Patients With Coronary 
Artery Disease 1073.122*18OA 
Long-Term Therapy With Enalapril Augments 
Endothelium Dependent Vasodilation in a Dose 
Dependent Manner in Patients With Congestive 
Heart Failure 1156-45.304A 
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Losartan and Captopril Reduce Myocardial Infarct 
Size, Arrhythmias, and Mortality in a Rat Model 
of lschemia-Reperfusion 1105-141 l 370A 
Low-tan Improves Endothelium-Dependent 
Vasodilation in Patients With Noninsulin 
Dependent Diabetes Mellitis 102346*246A 
Neither Previous Chlamydia Pneumoniae Infection 
nor Elevated C-Reactive Protein Are Associated 
With Endothelial Dysfunction in Healthy Young 
Adults 1201.43’327A 
Nitric Oxide Synthase lnbibition Improves Coronary 
Microcirculatory Function in Patients With 
Coronary Artery Disease 1191.30*482A 
Oral Folic Acid Treatment Improves Endothelial 
Function in Patients With 
Hyperhomocysteinemia 868-5 l 29lA 
Protective Effects of the Combiiation of 
Nonhypotensive Doses of Valsartan and 
Enalapril in Spontaneously Hypertensive Rats 
With End&&l Dysfunction 1025.17 l 248A 
Quantitative Relationship Between Cardiovascular 
Fitness and Endothelial Function 1089-44* 
212A 
Rapid Improvement of Endothelial Function After 
Lipid-Lowering Therapy With Cerivastatin 
Within Two Weeks 1046-9 *256A 
Relationships Between Genetic Predispositions to 
Hypertension and Coronary 
Endothelium-Dependent Vasodilation in 
Essential Hypertension 1204-17 l 331A 
Selective Impairment of End&helium-Dependent 
Vasadilatian of Resistance Vessels in Patients 
With Obstructive Sleep Apnea 868-2 *290A 
Serum Xanthine Oxidase and Nitric Oxide Synthase 
Activities and Malondialdehyde as Markers of 
Coronary Ischemia During Stress Test 1090-52 
l 2748 
Shoti-Term Endurance Exercise Training Enhances 
Endothelium-Dependent Vasodilation in Healthy 
Premenopausal Women 1073-121*179A 
Simultaneous Administration of Glycoprotein 
IIb/IIIa Inhibitors With Low-Molecular-Weight 
Heparins Does Not Augment the Release of 
Tissue Factor Pathway Inhibitor: Implications in 
the Management of Cardiovascular Patients 
1092-20 l 277A 
Soluble Forms of P-, and E-Selectin in Children 
With Immune Globulin-Resistant Kawasaki 
Disease 1146-162-5148 
SQ885, A Novel Nonpeptide Integrin Antagonist for 
Vascular Cell Integrins avb?, avb5, and aSb1 
Potently Inhibit An~ogenesis-Medicated 
Disorders 1157-53 l 306A 
Tamoxifen Is Not Detrimental to Endothelial 
Function in Women With Breast Cancer 
1045.45 l 254A 
The Direct Effects of Can&, Olive, and Fish Oils on 
Endothelial Function 860.6.2888 
The Effects of Oral Methionine and Homocysteine 
on Endothelial Function 860-5 l 2888 
The Influence of Short-Term Therapy With 
Simvastatin on Inflammatory Profile in 
Hypercholesterolemic Patients 1046-1’2*256A 
The Positive Inotropic Effects of Hydrostatic 
Pressure Are Buffered by the Endocardial 
Endothelim via Prostaglandins 1071-148 0 176A 
The Relation Between End&&al Dysfunction of 
Coronary Artery and Major Adverse Coronary 
Events 1061.1340354A 
The Selective Serotonin Reuptake Inhibitor 
Paroxetine Inhibits Endothelial-Dependent 
Vasodilation 1089-43 *271A 
Transient Hypertension Directly Impairs 
Endothelium-Dependent Vasodilation in Human 
Resistance Arteries 913-6 l 33.5A 
Troglitazone Improves Endothelial and Exercise 
Performance in Patients With Coronary Artery 
Disease 1196.107-4098 
Use of Elecrrical Stimulation to Prevent 
Atherosclerosis in the Abdominal Aorta 
(Experimental Study) 1022-S7*244A 
Vitawin E Prevents Resistance Vessel Endothelial 
Dysfunction Induced by Experimental 
Hyperhomocysteinemia in Human Subjects 
860-2 * 2878 
Endotbelium-derived relaxing factor 
Absence of L-Arginine Effect on the Coronary 
Hypersensitivity to Serotonin in Cardiac 
Transplant Recipients 120%120*238A 
Barorecepter Dysfunction Induced by Nitric Oxide 
Synthase Inhibition in Humans 868-l l 290A 
Comparative Effects of Paroxetine and Nefacodone 
on Human Platelet Aggregation and Vascular 
Reactivity 83%4*266A 
Effect of Chronic Exercise and Long-Term 
Angiotensin-Converting Enzyme Inhibitors on 
End&&al Function of Rat Thoracic Aorta 
1089.49 l 2738 
Effect of Intramuscular Gene Transfer With 
VEGFlZl on Endothelial Function in Patients 
With Peripheral Atherosclerotic Occlusive 
Disease 852-5 -279A 
Hypertriglyceridemia Is a Risk Factor for Arterial 
Endothelial Dysfunction in Asymptomatic 
Westernized Chinese 10%41.2458 
Sustained Improvement in Homocyst(e)ine Levels 
and Arterial Endothelial Function After 
One-Year Folic Acid Supplementation 868-60 
291A 
Synthetic Progestin Improves 
Endothelium-Dependent Vasodilator 
Responsiveness Comparable to Natural 
Progestin in Healthy Postmenopausal Women 
1023.48 02468 
Tetrahydrobiopterin Restores Endothelial Function 
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Disease? 884-3 l 473A 
Is Exercise Stress Testing Alone Useful in Patients 
With Cocaine Associated Chest Pain? 1127.141 
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Testing in Patients With Syndrome X? 
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Judicious Use of Radionuclide Myocardial Perfusion 
Imaging in an Emergency Department Chest 
Pain Center Optimizes the Triage of Patients 
With Chest Pain X84-4*474A 
Left Ventricular Ejection Fraction Following Acute 
Myocardial Infarction: Echo, MUGA and 
MRI-Preliminary Results From the MARRYEL 
Study X06-2 l 464A 
Myocardial Innervation After Percutaneous 
Myocardial Laser Revascularization 1196.103 l 
408A 
Myocardial Salvage in Patients With Non-ST 
Elevation Myocardial Infarction: Results Using 
Technetium-99m Sestamibi Myocardial 
Perfusion Imaging 1079.36*430A 
New Assessment of Systemic Sympathetic Activity 
With Skeletal Muscle 123 
I-Metaiodobenzylguanidine (MIBG) 
Scintigraphy in Patients of Chronic Heart 
Failure 1191-8*480A 
Nitrate-Enhanced Tc-99m Sestamibi Single Photon 
Emission Computed Tomography Is Comparable 
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and for Predicting Outcome in Patients With 
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Noninvasive Detection of Transplant Vasculopathy 
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Noninvasive Imaging of Atherosclerotic Plaques 
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Outcome Validation of a Stepwise Visual Approach 
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Perfusion Defects on SPECT Perfusion Imaging 
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With Electron Beam Computed Tomography for 
Coronary Calcification 904.4*484A 
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Prevalence and Significance of Exercise-Induced 
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Prognostic Significance of Rest 20lTl/Stress 
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Prognostic Significance of Transient Ischemic 
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Prognostic value of stress 
Technetium-99m-Sestamibi Myocardial 
Perfusion Imaging in Asymptomatic Diabetics 
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911.6*493A 
Quantitative Myocardial Perfusion Studies: 
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Technetium SPECT Studies 1032.4.4138 
Reduction in Stress Myocardial Ischemia by Basic 
Fibroblast Growth Factor (rFGF-2) in Severe 
Ischemic Heart Disease 879.4974A 
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Relationship Between T Wave Altemans and 
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Blood Volume 884- 1 l 4738 
Reversible Perfusion Defects on Thallium-201 
SPECT Scintigraphy Early After Coronary 
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Avoid Unnecessary Myocardial Imaging 
1034.33*417A 
Stress Modality for Myocardial Perfusion Imaging in 
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Stress SPECT Myocardial Perfusion Imaging for 
Predicting Future Cardiac Events in Diabetic 
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Stress Technetium-99m Sestamibi Gated SPECT 
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Cardiomyopathy 1079.40*431A 
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The Impact of Direct Percutaneous Myocardial 
Laser Revascularization (Biosense DMR) on 
Myocardial Perfusion and Function as Assessed 
by Gated SPECT Myocardial Perfusion 
Imaging: Results of the Phase I Multicenter 
DMR Trial 871-l 03838 
Usefulness of Iodine 123 Metaidobenzylguanidine 
Scintigmphy in Assessing Sympathetic 
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Adjunctive Infusion of a Novel P21-Receptor 
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Patients With and Without Diabetes 880-l - 
144A 
Rehabilitation 
A Comparison of Outcomes in Patients With and 
Without Left Ventricular Dysfunction 
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Hypertensive Patients With Electrocardiogram 
Left Ventricular Hypertrophy: The LIFE Study 
11X1-21*321A 
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Renal Artery Stenosis 1204.18.3328 
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Effect 1045.18.253A 
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Reperfusion 
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Beyond TIMI- Flow: The Importance of Restored 
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900.4 l 403A 
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Syndrome Family Members 1166-62*144A 
Comparison of a 60 Versus 90 Minute Measurement 
of ST-Segment Resolution After Thrornbolytic 
Therapy 1173-136*397A 
Diabetes Mellitus in Cardiogenic Shock 
Complicating Acute Myocardial Infarction: 
Report From the SHOCK Registry I1 16.1200 
196A 
Effects of Primary Percutaneous Transluminal 
Coronary Angioplasty on Time Course of Heart 
Rate Variability in Acute Myocardial Infarction: 
Early Versus Late Reperfusion 1173.134*397A 
Noninvasive Extraco~~oreal Venous Thrombolysis 
With Shock Waves 1180.48*319A 
Noninvasive Transthoracic Low Frequency 
Ultrasound Greatly Augments Thrombolysis in 
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1195-128.407A 
Platelet Glycoprotein IIb/TIIa Receptor Blockade 
After Failed Thrombolysis Is Associated With 
Risk of Bleeding 1106-101 l 37lA 
Postischemic Apoptosis and Functional Recovery 
After Angiotensin II Type 1 Receptor Blockade 
in the Isolated Working Rat Heart 1172-I 08 l 
395A 
Relative Prognostic Importance of Preserved 
Antegrade Coronary Blood Flow Before 
Compared to After Angioplasty in Patients 
Undergoing Primary Percutaneous Transluminal 
Coronary Angioplasty 1083-l 380 363A 
Repetiusion Therapy Among Paded Patients With 
Acute Myocardial Infarction 1173.131 l 396A 
Roles of Apoptosis and Cytokine Families on the 
Reperfusion Injury in the Patient With Acute 
Myocardial Infarction 1049.159*173A 
Stent PAMI: Twelve-Month Results and Predictors 
of Mortality 900. I l 402A 
The Relationship of Primary Angioplasty Volume 
and Survival Among Interventional Hospitals in 
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1062.83*20A 
Time Course and Prognostic Implications of 
QT-Interval Dynamicity and Variability After 
Successful Reperfusion by Primary 
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Angioplasty 1173.133*396A 
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What Should Be Done Acutely for Patients With 
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Reperfusion in Acute Myocardial Infarction? 
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Repolarization 
Beat-to-Beat QT Variability Identifies Myocardial 
Ischemia 1031-71 l 1OlA 
Comparison of Repolarization Abnormality During 
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Hypertrophic Cardiomyopathy 1076.600 114A 
Determinant of QT Dispersion in Patients With 
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Subjects 1166.60*143A 
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QT Dispersion: Repoltization Heterogeneity or 
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Findings of Multi-Link and GFX Stents 
1152-75 l 64A 
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